[1]
“the Relation of common ABL kinase domain mutations with resistance to Tyrosine Kinase Inhibiters in patients with Chronic Myeloid Leukemia in Middle Euphrates of Iraq: Chronic Myeloid Leukemia in Middle Euphrates of Iraq”, int.jour.sci.res.mana, vol. 8, no. 02, pp. 284–292, Feb. 2020, doi: 10.18535/ijsrm/v8i02.mp01.